disulfiram has been researched along with Inflammatory Breast Neoplasms in 2 studies
Inflammatory Breast Neoplasms: Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arora, J | 1 |
Sauer, SJ | 1 |
Tarpley, M | 1 |
Vermeulen, P | 1 |
Rypens, C | 1 |
Van Laere, S | 2 |
Williams, KP | 1 |
Devi, GR | 2 |
Dewhirst, MW | 1 |
Allensworth, JL | 1 |
Evans, MK | 1 |
Bertucci, F | 1 |
Aldrich, AJ | 1 |
Festa, RA | 1 |
Finetti, P | 1 |
Ueno, NT | 1 |
Safi, R | 1 |
McDonnell, DP | 1 |
Thiele, DJ | 1 |
2 other studies available for disulfiram and Inflammatory Breast Neoplasms
Article | Year |
---|---|
Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
Topics: Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Culture Techniques; Cell Survival; Copper; Di | 2017 |
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Copper; Disulfiram; Female; Humans; Inflammatory Breast Neo | 2015 |